AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27973936 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 20
Study 25072937 — intervention group
Group type: EXPERIMENTAL
Intervention: Nω‐hydroxy‐nor‐L‐arginine (0.1 mg/min)
Number of subjects: 24
Study 25072937 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 24
Study 22594233 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser irradiation after root canal therapy and conservative periodontal treatment
Number of subjects: 30
Study 22594233 — intervention group
Group type: COMPARATOR
Intervention: Root canal therapy and conservative periodontal treatment (scaling and root planning)
Number of subjects: 30
Study 15759529 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic muscle stretch (20-min session)
Number of subjects: 66
Study 15759529 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic muscle stretch (20-min session)
Number of subjects: 66
Study 15759529 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 66
Study 12218231 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% RAL
Number of subjects: 22
Study 12218231 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 22
Study 9856368 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil (240 mg once a day)
Number of subjects: 498
Study 9856368 — intervention group
Group type: COMPARATOR
Intervention: chlorthalidone (25 mg once a day)
Number of subjects: 498
Study 9856368 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 498
Study 9856368 — intervention group
Group type: COMPARATOR
Intervention: chlorthalidone
Number of subjects: 498
Study 7874947 — intervention group
Group type: EXPERIMENTAL
Intervention: Guaifenesin
Number of subjects: 10
Study 7874947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2133226 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline therapy
Number of subjects: 0
Study 484632 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 33
Study 484632 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 33
Study 484632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 29137968 — intervention group
Group type: EXPERIMENTAL
Intervention: Displayed bundles of healthy foods with a price discount
Number of subjects: 0
Study 29137968 — intervention group
Group type: EXPERIMENTAL
Intervention: Displayed bundles of healthy foods without a price discount
Number of subjects: 0
Study 29137968 — intervention group
Group type: COMPARATOR
Intervention: No bundles displayed (control condition)
Number of subjects: 0
Study 29098262 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid prototyping technology
Number of subjects: 120
Study 29098262 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods
Number of subjects: 120
Study 25495719 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin 4 mg daily for 12 weeks
Number of subjects: 163
Study 25495719 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine 4 mg daily for 12 weeks
Number of subjects: 163
Study 24197772 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary calcium intake and 25 hydroxy vitamin D status
Number of subjects: 305
Study 24197772 — intervention group
Group type: EXPERIMENTAL
Intervention: High bone turnover
Number of subjects: 305
Study 24197772 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake
Number of subjects: 305
Study 24197772 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlates of high bone turnover
Number of subjects: 305
Study 20082737 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flavanol cocoa beverage (701 mg)
Number of subjects: 21
Study 20082737 — intervention group
Group type: COMPARATOR
Intervention: Low-flavanol cocoa beverage (22 mg)
Number of subjects: 21
Study 19057628 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural injections with local anesthetic (lidocaine 0.5%)
Number of subjects: 40
Study 19057628 — intervention group
Group type: COMPARATOR
Intervention: Caudal epidural injections with 0.5% lidocaine mixed with 1 mL of 6 mg non‐particulate Celestone
Number of subjects: 40
Study 19057628 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural injections (both groups)
Number of subjects: 40
Study 17000387 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair (LAP)
Number of subjects: 1395
Study 17000387 — intervention group
Group type: COMPARATOR
Intervention: Open hernia repair (OPEN)
Number of subjects: 1395
Study 15030113 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual decision-making
Number of subjects: 55
Study 15030113 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-compensatory decision strategies
Number of subjects: 55
Study 15030113 — intervention group
Group type: EXPERIMENTAL
Intervention: Reception of decision-threatening information
Number of subjects: 55
Study 15030113 — intervention group
Group type: EXPERIMENTAL
Intervention: Single task-oriented group members
Number of subjects: 55
Study 15030113 — intervention group
Group type: EXPERIMENTAL
Intervention: Groups with a task-oriented leader
Number of subjects: 55
Study 10897159 — intervention group
Group type: EXPERIMENTAL
Intervention: LEV 1,000 mg
Number of subjects: 246
Study 10897159 — intervention group
Group type: EXPERIMENTAL
Intervention: LEV 3,000 mg
Number of subjects: 246
Study 10897159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study 8604240 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 cycles of the combination of cyclophosphamide (500 mg/m2), mitoxantrone (10 mg/m2), and fluorouracil (500 mg/m2; CNF)
Number of subjects: 362
Study 8604240 — intervention group
Group type: COMPARATOR
Intervention: 6 cycles of conventional CMF
Number of subjects: 362
Study 1420740 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine administered at bedtime
Number of subjects: 12
Study 1420740 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine administered post evening meal
Number of subjects: 12
Study 3909330 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam plus clindamycin
Number of subjects: 66
Study 3909330 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin plus clindamycin
Number of subjects: 66
Study 31473172 — intervention group
Group type: EXPERIMENTAL
Intervention: IAI 2 mg every 4 weeks (2q4)
Number of subjects: 106
Study 31473172 — intervention group
Group type: EXPERIMENTAL
Intervention: IAI 2 mg every 8 weeks (2q8)
Number of subjects: 106
Study 29882843 — intervention group
Group type: EXPERIMENTAL
Intervention: WBE111 (100 mg)
Number of subjects: 122
Study 29882843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 27418883 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA (0.17 g/kg), arginine (0.05 g/kg), citrulline (0.05 g/kg)
Number of subjects: 12
Study 27418883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 24884934 — intervention group
Group type: EXPERIMENTAL
Intervention: Instant Oatmeal (IO)
Number of subjects: 48
Study 24884934 — intervention group
Group type: EXPERIMENTAL
Intervention: Old-Fashioned Oatmeal (SO)
Number of subjects: 48
Study 24884934 — intervention group
Group type: COMPARATOR
Intervention: Ready-to-Eat Cereal (RTEC)
Number of subjects: 48
Study 21857372 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrated exercise (0%-1% of body mass)
Number of subjects: 10
Study 21857372 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydrated exercise (-1% to -2% of body mass)
Number of subjects: 10
Study 21857372 — intervention group
Group type: COMPARATOR
Intervention: Hydrated resting control
Number of subjects: 10
Study 21857372 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydrated exercise
Number of subjects: 10
Study 20979906 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg by muscle injection
Number of subjects: 100
Study 20979906 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline 2 ml
Number of subjects: 100
Study 18783360 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional pain therapies
Number of subjects: 0
Study 18783360 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 15797965 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 71
Study 15797965 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS group with baseline IGT
Number of subjects: 71
Study 15797965 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS group with normal glucose tolerance (NGT) at baseline
Number of subjects: 71
Study 15797965 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 71
Study 12147929 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 89
Study 12147929 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ)
Number of subjects: 89
Study 12147929 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor/HCTZ combinations
Number of subjects: 89
Study 12147929 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitors
Number of subjects: 89
Study 12147929 — intervention group
Group type: COMPARATOR
Intervention: Beta blockers
Number of subjects: 89
Study 12147929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 10358862 — intervention group
Group type: EXPERIMENTAL
Intervention: Diovan (valsartan) 80 mg/day for 8 weeks, increased to 160 mg/day if needed
Number of subjects: 20
Study 7866213 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise screening
Number of subjects: 2002
Study 7866213 — intervention group
Group type: COMPARATOR
Intervention: Couple screening
Number of subjects: 2002
Study 7866213 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 2002
Study 1782973 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine phosphate 100 mg
Number of subjects: 8
Study 1782973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1782973 — intervention group
Group type: COMPARATOR
Intervention: Codeine phosphate 100 mg with quinidine sulphate 50 mg pretreatment
Number of subjects: 8
Study 1782973 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine phosphate 100 mg in PM
Number of subjects: 8
Study 1782973 — intervention group
Group type: COMPARATOR
Intervention: Quinidine sulphate 50 mg
Number of subjects: 8
Study 6113821 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug alone
Number of subjects: 228
Study 6113821 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 228
Study 6113821 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy alone
Number of subjects: 228
Study 6113821 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy plus drug
Number of subjects: 228
Study 6113821 — intervention group
Group type: EXPERIMENTAL
Intervention: Milieu
Number of subjects: 228
Study 31596793 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual audit instrument using Google Street View imagery
Number of subjects: 375
Study 30412277 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol + ILE
Number of subjects: 10
Study 30412277 — intervention group
Group type: COMPARATOR
Intervention: ILE
Number of subjects: 10
Study 28500394 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise (RVE)
Number of subjects: 9
Study 28500394 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 9
Study 25444356 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting glucose and lipids added to a validated risk prediction tool for GDM
Number of subjects: 222
Study 25444356 — intervention group
Group type: COMPARATOR
Intervention: Validated risk prediction tool for GDM
Number of subjects: 222
Study 25444356 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted models for GDM diagnosis
Number of subjects: 222
Study 23715753 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec 200 units/mL once daily
Number of subjects: 457
Study 23715753 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine 100 units/mL once daily
Number of subjects: 457
Study 20660540 — intervention group
Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg
Number of subjects: 147
Study 20660540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 19270299 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment with sulfadoxine‐pyrimethamine (IPTp‐SP) with community-based promotional activities
Number of subjects: 2240
Study 19270299 — intervention group
Group type: COMPARATOR
Intervention: Intermittent preventive treatment with sulfadoxine‐pyrimethamine (IPTp‐SP) without community-based promotional activities
Number of subjects: 2240
Study 19270299 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment with sulfadoxine‐pyrimethamine (IPTp‐SP) during low transmission season
Number of subjects: 2240
Study 17171563 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track surgery regimen
Number of subjects: 50
Study 17171563 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery regimen
Number of subjects: 50
Study 15516639 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic oral iron supplementation (2 mg/kg/day)
Number of subjects: 832
Study 15516639 — intervention group
Group type: COMPARATOR
Intervention: No iron supplementation (Control)
Number of subjects: 832
Study 11226441 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol 100 microg, repeated once after 6 h if not in active labor
Number of subjects: 96
Study 11226441 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two doses of vitamin C after a 6-h interval)
Number of subjects: 96
Study 9686662 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers with gestational diabetes
Number of subjects: 20
Study 9686662 — intervention group
Group type: EXPERIMENTAL
Intervention: Newborns of mothers with gestational diabetes
Number of subjects: 20
Study 9686662 — intervention group
Group type: COMPARATOR
Intervention: Control group mothers
Number of subjects: 20
Study 9686662 — intervention group
Group type: COMPARATOR
Intervention: Control group newborns
Number of subjects: 20
Study 8008686 — intervention group
Group type: EXPERIMENTAL
Intervention: LSA/BXO cases (20 patients)
Number of subjects: 20
Study 8008686 — intervention group
Group type: COMPARATOR
Intervention: Control specimens (12 non‐LSA/BXO balanitis)
Number of subjects: 20
Study 8008686 — intervention group
Group type: COMPARATOR
Intervention: Control specimens (3 controls with clinical features suggestive of LSA/BXO)
Number of subjects: 20
Study 2663518 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin in combination with ampicillin
Number of subjects: 35
Study 2663518 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime in combination with ampicillin
Number of subjects: 35
Study 2663518 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 35
Study 31254718 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitrite (0.6 mg/kg/h)
Number of subjects: 21
Study 31254718 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sodium chloride)
Number of subjects: 21
Study 28409508 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine supplementation (6 mg.kg-1 30 minutes before tests)
Number of subjects: 8
Study 28409508 — intervention group
Group type: COMPARATOR
Intervention: Placebo with starch supplementation
Number of subjects: 8
Study 28409508 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine supplementation (mean of C1 and C2)
Number of subjects: 8
Study 28409508 — intervention group
Group type: COMPARATOR
Intervention: Basal without caffeine
Number of subjects: 8
Study 27966504 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) as an adjunct to scaling and root planing (SRP)
Number of subjects: 20
Study 27966504 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 20
Study 24885101 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention including education, supervision, and technical support
Number of subjects: 200
Study 24885101 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study 22870302 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride solution (5%)
Number of subjects: 40
Study 22870302 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride solution (1% or 2%)
Number of subjects: 40
Study 22870302 — intervention group
Group type: COMPARATOR
Intervention: Control (distilled water)
Number of subjects: 40
Study 20631019 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking at 75% of maximal heart rate for 75 min
Number of subjects: 21
Study 20631019 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control condition
Number of subjects: 21
Study 18808624 — intervention group
Group type: EXPERIMENTAL
Intervention: Si‐Wu‐Tang (SWT) 15 g daily for seven consecutive days after cessation of menstrual bleeding
Number of subjects: 49
Study 18808624 — intervention group
Group type: COMPARATOR
Intervention: Si‐Wu‐Tang (SWT) 15 g daily as soon as menstrual bleeding is noted
Number of subjects: 49
Study 16206458 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine and/or stavudine
Number of subjects: 65
Study 16206458 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine and lamivudine
Number of subjects: 65
Study 16206458 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV+ individuals not currently taking antiretrovirals
Number of subjects: 65
Study 16206458 — intervention group
Group type: COMPARATOR
Intervention: HIV- controls
Number of subjects: 65
Study 11545641 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified visual acuity testing protocol using isolated surrounded HOTV optotypes
Number of subjects: 178
Study 11545641 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified visual acuity testing protocol
Number of subjects: 178
Study 9058001 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive rehabilitation (CACR)
Number of subjects: 20
Study 9058001 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (various other therapies including speech therapy and occupational therapy)
Number of subjects: 20
Study 8271168 — intervention group
Group type: EXPERIMENTAL
Intervention: Amvisc Plus
Number of subjects: 49
Study 8271168 — intervention group
Group type: COMPARATOR
Intervention: Viscoat
Number of subjects: 49
Study 2887186 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (243 +/- 26 mg daily)
Number of subjects: 15
Study 2887186 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (149 +/- 16 mg daily)
Number of subjects: 15
Study 2887186 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (50 +/- 8 mg daily)
Number of subjects: 15
Study 2887186 — intervention group
Group type: COMPARATOR
Intervention: CWT (Colour Word Test)
Number of subjects: 15
Study 2887186 — intervention group
Group type: COMPARATOR
Intervention: ORT (Orthostatic Testing)
Number of subjects: 15
Study 2887186 — intervention group
Group type: COMPARATOR
Intervention: CPT (Cold Pressor Test)
Number of subjects: 15
Study 2887186 — intervention group
Group type: COMPARATOR
Intervention: Visual analogue scales for stress and irritation
Number of subjects: 15
Study 2887186 — intervention group
Group type: COMPARATOR
Intervention: Self ratings of tiredness
Number of subjects: 15
Study 2887186 — intervention group
Group type: COMPARATOR
Intervention: Performance in CWT
Number of subjects: 15
Study 2919849 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (10 mg)
Number of subjects: 10
Study 2919849 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (20 mg)
Number of subjects: 10
Study 2919849 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 10
Study 31162709 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal designs in three-level cluster randomized trials with a binary outcome
Number of subjects: 0
Study 31162709 — intervention group
Group type: EXPERIMENTAL
Intervention: MaxiMin design
Number of subjects: 0
Study 28465224 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoe orthotics
Number of subjects: 225
Study 28465224 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoe orthotics plus chiropractic treatment
Number of subjects: 225
Study 28465224 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (no treatment)
Number of subjects: 225
Study 26055635 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 min CCT
Number of subjects: 68
Study 26055635 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 min CCT
Number of subjects: 68
Study 26055635 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 min CCT
Number of subjects: 68
Study 26055635 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 68
Study 23114033 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride followed by laser treatment
Number of subjects: 0
Study 23114033 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 0
Study 23114033 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride treatment
Number of subjects: 0
Study 23114033 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 23364504 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodality chest physiotherapy
Number of subjects: 173
Study 23364504 — intervention group
Group type: COMPARATOR
Intervention: MH and suctioning (control group)
Number of subjects: 173
Study 19537524 — intervention group
Group type: EXPERIMENTAL
Intervention: DoloVisano Methocarbamol 750 mg (test product)
Number of subjects: 32
Study 19537524 — intervention group
Group type: COMPARATOR
Intervention: Registered reference product (reference product)
Number of subjects: 32
Study 19537524 — intervention group
Group type: COMPARATOR
Intervention: Comparison of test and reference products
Number of subjects: 32
Study 16446056 — intervention group
Group type: EXPERIMENTAL
Intervention: Efaproxiral arm
Number of subjects: 515
Study 16446056 — intervention group
Group type: COMPARATOR
Intervention: Control arm (WBRT without efaproxiral)
Number of subjects: 515
Study 15515038 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min daily exposure to static magnetic fields (4 patients)
Number of subjects: 11
Study 15515038 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 min daily exposure to static magnetic fields (7 patients)
Number of subjects: 11